MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

Model Number 10220

Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)

Patient Problems Diarrhea (1811); Fever (1858); Septic Shock (2068)

Event Date 10/15/2022

Event Type  Injury  

Manufacturer Narrative

Lot number and expiry are not available at this time.Article citation: menegotto, p.R.,soares, t.,santin, a.,eckert, d.,hackner, i.,fassina, k.,morsch, k.T.,lindenmeyer, l.,capra, m.2022.Experiência de um serviço público de porto alegre-rs com os primeiros pacientes submetidos ao transplante de células tronco hematopoiéticas.Hematology, transfusion and cell therapy.44:s312-s313 investigation is in process.A follow up report will be provided,.

Event Description

The conference abstract, 'experiência de um serviço público de porto alegre-rs com os primeiros pacientes submetidos ao transplante de células tronco hematopoiéticas' was published 15oct2022.The abstract is not in english and was preliminarily translated using google translate.The article, 'experience of a public service in porto alegre-rs with the first patients undergoing hematopoietic stem cell transplantation' discusses a descriptive study on patients undergoing hematopoietic stem cell transplantation (hsct).Per the article, the most frequent complications of donor before the procedure were mucositis (grade 1, n = 2; grade 2, n=4; grade 3, n = 1; ctcae v5.0), febrile neutropenia (grade 3, n = 8; ctcae v5.0) and diarrhea (grade 1, n = 5, grade 2, n = 3; ctcae v5.0).One patient had septic shock, being transferred injured to the intensive care unit, with recovery and return to the inpatient unit in 4 days.The article does not provide individual patient information, therefore this report is being submitted as a summary of events.The exchange sets are not available for return for evaluation.

Manufacturer Narrative

This report is being filed to provide additional information in h.6 and h.10, and corrected information in d.2a and d.4.Article citation: menegotto, p.R.,soares, t.,santin, a.,eckert, d.,hackner, i.,fassina, k.,morsch, k.T.,lindenmeyer, l.,capra, m.2022.Experiência de um serviço público de porto alegre-rs com os primeiros pacientes submetidos ao transplante de células tronco hematopoiéticas.Hematology, transfusion and cell therapy.44:s312-s313 investigation: since this is a journal publication presenting data of eight patients submitted to autologous hematopoietic stem cells (hsct) since december 2021 with unknown procedural dates, the lot numbers were not requested; therefore, a dhr search could not be conducted for this specific incident.All lots must meet acceptance criteria for release.All the reported adverse reactions were anticipated side effects of chemotherapy, mobilization regimen, and/or conditioning protocols, and hence, unrelated to the performance of spectra optia.Only the one report of septic shock is investigated in order to rule out possible device malfunction.According to the aabb circular of information for the use of human blood components (revised 2017), because whole blood and blood components are made from human blood, they may carry a risk of transmitting infectious agents [eg, viruses, bacteria, parasites, the variant creutizfeldt-jakob disease (vcjd) agent, and, theoretically, the cjd agent].Careful donor selection, available laboratory tests, and pathogen inactivation (when it is utilized) do not totally eliminate these hazards.Also, septic and toxic reactions can result from transfusion of bacterially contaminated blood and blood components.Such complications are infrequent but may be life-threatening.Bacterial sepsis occurs rarely but can cause acute, severe, sometimes life-threatening effects.Onset of high fever (>2 c or > 3.5 f increase in temperature), severe chills, hypotension, or circulatory collapse during or shortly after transfusion should suggest the possibility of bacterial contamination and/or endotoxin reaction in the transfused products.Experience of a public service of porto alegre-rs with the first patients undergoing transplantation of hematopoietic stem cells per internal sterility documentation, the devices terumo bct manufactures to collect, separate, and store blood products are terminally sterilized to a sterility assurance level (sal) of

Event Description

The conference abstract, 'experiência de um serviço público de porto alegre-rs com os primeiros pacientes submetidos ao transplante de células tronco hematopoiéticas' or "experience of a public service of porto alegre-rs with the first patients undergoing transplantation of hematopoietic stem cells" was published 15oct2022.The abstract is not in english and was preliminarily translated using google translate.The article, 'experience of a public service in porto alegre-rs with the first patients undergoing hematopoietic stem cell transplantation' discusses a descriptive study on patients undergoing hematopoietic stem cell transplantation (hsct).Per the article, the most frequent complications of donor before the procedure were mucositis (grade 1, n = 2; grade 2, n=4; grade 3, n = 1; ctcae v5.0), febrile neutropenia (grade 3, n = 8; ctcae v5.0) and diarrhea (grade 1, n = 5, grade 2, n = 3; ctcae v5.0).One patient had septic shock, being transferred injured to the intensive care unit, with recovery and return to the inpatient unit in 4 days.The article does not provide individual patient information, therefore this report is being submitted as a summary of events.This is a journal publication presenting data of eight patients submitted to autologous hematopoietic stem cells (hsct) since december 2021 with unknown procedural dates.A request for specific patient information is not feasible.The exchange sets are not available for return for evaluation.

• Brand Name: SPECTRA OPTIA
• Type of Device: SPECTRA OPTIA IDL SET
• Manufacturer (Section D): TERUMO BCT; lakewood CO 80215
• Manufacturer (Section G): TERUMO BCT; 10810 w. collins ave; lakewood CO 80215
• Manufacturer Contact: scot hilden ; 10810 w. collins ave; lakewood, CO 80215
• MDR Report Key: 16216374
• MDR Text Key: 307816059
• Report Number: 1722028-2023-00023
• Device Sequence Number: 1
• Product Code: GKT
• UDI-Device Identifier: 05020583103108
• UDI-Public: 05020583103108
• Combination Product (y/n): N
• Reporter Country Code: BR
• PMA/PMN Number: BK150251
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Foreign,Literature,Health Professional
• Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date: 01/20/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Operator: Health Professional
• Device Model Number: 10220
• Device Catalogue Number: 10310
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Initial Date Manufacturer Received: 12/28/2022
• Initial Date FDA Received: 01/20/2023
• Supplement Dates Manufacturer Received: 01/31/2023
• Supplement Dates FDA Received: 02/13/2023
• Was Device Evaluated by Manufacturer?: No
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Patient Outcome(s): Other